You are here Research


In a country in which there is little encouragement for team work in research, in which research in academia is undertaken to obtain promotion rather than contribute to national development, and in which publication in international peer-reviewed journals is infrequent when numbers of publications are compared to numbers of researchers, the NCDEG stands out as an exception. It has a team of well-trained researchers whose goal is to reduce the incidence and impact of a set of diseases for which the prevalence in Jordan is unusually high 30. They publish as group four or five papers per year in international journals while also offering patient care in a clinic with about 3.000 patients.

In recognition of the quality of its research, the Centre has been designated as a World Health Organization Collaborating Centre for Diabetes Research, Education and Primary Health Care. According to WHO, “criteria for selection (as a collaborating center) include the scientific and technical standing of the institution, its actual level of commitment at national regional and international level, and its ability to strengthen national and regional capacity for health development. The institution must also have collaborated successfully with WHO for at least two years in carrying out jointly planned activities. WHO collaborating centers must have the capacity and the institutional stability to develop relation with other institutions through shared activities and networking.”
• = Abstract  ** = Letter  *** = Book

1. K. Ajlouni, Untersuchunger uber das Yoshida - Ascites - Sarkom der Ratte IM Zusammenhang mit dem Freund - Kaminerischen Phaenomen. Universitat Heidelberg, February 1966 ( Inauguration Thesis).

2. K. Ajlouni & T. Branigan, Pacemaker Therapy in Acute and Chronic Heart Block, Mercy Hospital Bulletin, Buffalo, New York, 1970.

3. K. Ajlouni & G.B. Theil, Mithramycin Effect on Calcium  and Phosphorus and Parathyroid Hormone in Osseous Paget's Disease. Clin. Res.  21.883,  1973*.

4. K. Ajlouni &  T. D.  Doeblin: The Syndrome of Hepatitis and Aplasitc  Anemia Brit. J. Haem 1974 Jun;27 (2): 345-55..

5. K. Ajlouni, M. Kern, J. Tures, T.C. Hagen & G.B. Theil, Thiothixene Induced Hyponatraemia. Arch. Int. Med. 1974 Dec; 134:1103-1105-5,.

6. K. Ajlouni, W. Millman, J.A. Libnoch & G.B. Theil, Hyperphosphatemia and Hypocalcemia in Myeloproliferative Disorder. Ann. Int. Med. 1974 Jul;81 (1):119-20

7. K. Ajlouni & P.S. Rosenfeld, Treatment of Hypercalcemia Drug Therapy 4:103-111, 1974.

8. K. Ajlouni & T.C. Hagen, Growth Hormone Response to Oral Glucose in stable and Hypoglycemia-Prone Diabetics 23:351, 1974*.

9. A. R. Guansing,  , Y. Leung, K. Ajlouni & T.C. Hagen, The Effect of Hypoglycemia on TSH Release in Man. Clinc. Res. 22:599A, 1974*.

10. Y. Leung, A. R. Guansing, K. Ajlouni & T.C. Hagen, Hypoglycemia, A Potent Stimulator of the hypothalmic- Pituitary - Thyroid Axis. Clin. Res. 22: 599A, 1974*.

11. K. Ajlouni & T. C. Hagen, The Effect of Calcium on Growth Hormone Release in Man. Clin. Res. 22: 615A, 1974*.

12. K. Ajlouni, D. R. Martinson & T. C. Hagen, The Effect of Glucose on the Growth Hormone Response to L-Dopa in Diabetic and Normal Subjects. Clin. Res. 22: 616A, 1974*.

13. A. R. Guansing, Y, Leung, K. Ajlouni & T.C. Hagen, The Effect of Hypoglycemia on TSH Release in Man. J. Clin. Endocrin. Metab. 40:755-758, 1975.

14. K. Ajlouni & T.C. Hagen, The Effect of Acute Hypercalcemia on Growth Hormone Release in Man. J. Clin. Endocrinol. Metab. 1975 May 40 (5) : 780-782,.

15. T. C. Hagen & K. Ajlouni, Growth Hormone Response to Oral Glucose in Stable and Hypoglycemia-Prone Diabetics. Proc. Soc. Exp. Biol. Med. 1975 May;149 (1) : 223-226,.

16. K. R. Shetty, K. Ajlouni, P. S. Rosenfeld & T. C. Hagen, Protracted Vitamin D  Intoxication. Arch. Int. Med. 1975 Jul; 135 (7) : 986-8.

17. K. Ajlouni & T. C.  Hagen, The Effect of Glucose on Growth Hormone Respone to L-DOPA in Diabetic and Normal Subjects. Diabetes 1975 Jul; 24 (7) : 633-636,.

18. Y. Leung, A. R. Guansing, K. Ajlouni, T. C. Hagen, P. S. Rosenfeld & J. J. Barboriak, The Effect of Hypoglycemia on Hypothalmic Thyrotrophin Releasing Hormone (HRH) In The Rat. Endocrinology 1975 Aug; 97 (2) : 380- 384,.

19. K. Ajlouni & G. B. Theil, The Effects of Mithramycin on Calcium. Phosphorus and Parathyroid Hormone Metabolism in Osseous Paget's Disease. Am. J. Med. Sci. 1975 Jan-Feb; 269 (1):13-8,.

20. A. R.  Guansing, Y. Leung, K. Ajlouni & T. C. Hagen, Hypolycemia, A Non-Thyrotrophin Releasing Hormone (TRH) Mediatd Stimulus To Prolactin Release (PRL) in Rats. Clin. Res. 23:236A, 1975*

21. K. Ajlouni, D. R. Martinson & T. C. Hagen, Failure of Acute and Chronic Hyperglycemia in Suppressing The Growth Hormone Response of  L-dopa in Diabetics. Diabetes 24:407, 1975.

22. A. R. Guansing, Y. Leung, K. Ajlouni, L. Murk, J. Chakravarty & T. C. Hagen, Nyctohemeral Variation in Hypothalmic (HTH) Thyrotrophin-Releasing Hormone (TRH) Content in Rats. Clin. Res. 24:272A, 1976*.

23. V.S. Bamrah, K. Ajlouni, W. H. Squires, C. V. Hughes, P.S Rosenfeld & F. E. Tristani, Aortic Regurgitation and Pigmentation - Unusual Features of Noonan Syndrome. Am. J. Med. Sci. 1976 Mar; 271 (2):211-4,.

24. K. Ajlouni,  Glucagon in diabets. J. M.J., 1976.

25. K. Ajlouni, A.J. Sill & T. C. Hughes, Glucoregulation of Prolactin Secretion. Diabetes 25:351, 1976*.

26. B. Varke, A. Funahashi, K. Ajlouni & S. H. Tsung, Protease Inhibitor System and Pulmonary FunctionStudies in Klinefelter's Syndrome. (American Review of Respiratory) Disease. Vol. 130, No. 14, 1976*.

27. J. A. Libnoch, K. Ajlouni, W. Millman, A. R. Guansing & G. B. Theil Acute Myelofibrosis with Malignant Hypercalcemia. Am. J. Med 1977 Mar; 62 :432-438,.

28. K. Ajlouni & M. Tarawneh, Review of Thyroid Function Tests. J. M. J. Vol. 12, No. 2, 60-69, 1977.

29. .G. B. Theil & K. Ajlouni, Effect of Mitharamycin on Hydroxyproline Metabolism in Paget's Disease. Journal of Lab and Clinical Medicine 1977 Nov;Vol. 90, No. 5, 803- 809,

30. K. Ajlouni et. al., Consultant for Chapter Drug Affecting Calcium Metabolism in the AMA Drug Evaluation Book. 3rd Edition, Year 1977. Science Publisher Inc.

31. 30.S. H. Tsung. & K. Ajlouni, Immune Competence in Patients with Klinefelter's Syndrome (The American Journal of the Medical Sciences), 1978 May – June; Vol. 275, No. 3, 311-317,.

32. K. Ajlouni, Diagnosis and Treatment of Endocrine Causes of Short Stature. J. M. J.  Vol. 13, No. 1, 36-44, 1978.

33. W.L. Millman, K. Ajlouni, M. G. Heckman & G. B. Theil, Hypercalcemia, Metastatic Calcifications and Cardiac Abnormalities. Wisconsin Medical Journal,  1978  Sep; Vol. 77 (9), S91-S94,

34. K. Ajlouni et. al., Hyperthyroidism in Jordan. J. M. J. 14:1, 17-23, 1980.

35. K. Ajlouni  et. al., Management of Diabetes Insipidus, J. M. J.  14:1, 55-62, 1980.

36. K. Ajlouni, Habab & Tarawneh, Malaria  and Typhoid Concomittant Infections, Brief Communication. J. M. J. 14:1, 105-108, 1980.

37. K. Ajlouni & T. C. Hagen, Growth Hormone and Prolactin Abnormalities in Diabetics. Proceeding Arab Emirates Medical Journal, Vol. 1, No. 2, 53-58, 1980.

38. K. Ajlouni & M. Khatib, The Effect of Glucose on Growth Hormone Response to Diazepam. Clinical Research,  Vol. 28, No. 2, 384, 1980.

39. K. Ajlouni & M. Khatib, The Effect of Growth Hormone TSH and Prolactin Response in Normal Subject. Hormone Research, Vol. 13: 160-164 (1980).

40. K. Ajlouni & M. Khaitb, The Effect of Acute Hypercalcemia on Prolactin Release in Normals. Clinical Research, October, 1980.

41. K. Ajlouni & M. Khatib, The Effect of Hyperglycemia on GH Response to Diazepam in Diabetics. Clinical Research, October 1980.

42. K. Ajlouni & M. Khatib, The Effect of Acute Hypercalcemia on Prolactin Release in Normal Subjects. Hormone Metabolic Research, Vol. 13, No. 5, 281-284, 1981.

43. T. C.  Hagen, K. Ajlouni, D. R. Martinson & A. J. Sill, Glucoregulation of Prolactin Secretion. J. M. J. Vol. 15, 45-52, 1981.

44. K. Ajlouni & Dawani, The Use of Mono-Component Insulin in the Treatment of Insulin Resistance. J. M. J. Vol. 15, No. 1, 95-100, 1981.

45. K. Ajlouni & S. Dahabrah, Hyper Pseudo Psuedo Hypo Parathyroidism, Kuwaiti Medical Journal. 15, (3), 185-189, 1981.

46. K. Ajlouni  et. al. Thyroid Disorders in Jordan - Abstract, Proceedings of American Thyroid Association Meeting, October 1981.

47. K. Ajlouni,  M. El-Khateeb , M. EL-Zaheri A., EL-Najdawi The Response of Growth Hormone and prolactin to oral Diazepam in Diabetics ,. Journal of Endocrinological investigation. 5: 157-159, 1982.

48. K. Ajlouni  et. al., Intenstinal Obstruction and Pregnancy. J. M. J. 16, 2: 169-172, 1982.

49. K. Ajlouni et. al., Non- Secretory Tumor of the Islet Cells of the Pancreas. J. M. J.  16, 2: 158- 162, 1982.

50. K. Ajlouni, The Failure of Diazepam to Affect Growth Hormone and Prolactin in Acromegalics. Hormone - Research 1983; 18 (4): 186-190.

51. K. Ajlouni et. al.,  11-B Hydroxylase Deficiency with Pulmonary Stenosis and Skeletal Abnormalities. J. Endocrinol. Invest. 1984. Apr; 7(2) :129, 31

52. T. C. Hagen, A. M. Lawrence, K. Ajlouni, Chronic Propranolol Administration Impairs Glucagon Release During Insulin- Induced Hypoglycemia in Normal Man. J. Endocriol & Metab. 1984. Oct; 59 (4): 622- 624.

53. K. Ajlouni et. al., Primary Empty Sella Syndrome with  Panhypopituitarism in a  Child. Helv. Paed. Acta, 1984 Dec; 39 (5-6): 473-479,.

54. K. Ajlouni et. al., Absence of the Pectoralis Major and Dextro Cardia without Skeletal Abnormalities - A Variant of the Poland Syndrome. J.M.J. Nov. 1986.

55. M. A. Arnaout, R. Amari, K. Ajlouni, D. Martinson, T. Garthwaite, & T. C. Hagen, Different PRL and GH Responses to Vasoactive Intestinal Peptide in Patients with Hyperprolactinemia. Clinical Research, Vol. 34, No. 4, 1986.

56. Daradkeh T., Ajlouni K., Abu Hajir M.,Sleep-Walking as a symptom of Thyrotoxicosis, Dirasat Volume XIV (1987 ) Number 6: 143-146.

57.  K. Ajlouni, N. A. Sliman, A. Najdawi, M.M. Abu- Hajir, & M.A. Arnaout, Effect of Exposure to the Altitude of 300 Meters Below Sea - level on Testosterone, Luteinizing Hormone, Folicle-Stimulating Hormone and Prolactin in Man. J. Endocrinol. Invest. 1988 Sep; 11 (8): 621-623,.

58.  M.A. Arnaout, K Ajlouni & I. Jalal, Effect of Different Glibenclamide Formulas on Blood Levels of Immunoreactive Insulin and Glucose in Noninsulin- Dependent Diabetics. Current Therapeutic Research, Vol. 44 NO. 6, 1988.

59. T. K. Daradkeh &  K. Ajlouni, The Effect of Neuroleptics on Prolactinoma Growth in A Jordanian Schizophrenic Girl. Acta Psychiatr Scand., 1988 Feb ;77 (2): 228-229,.

60. K. Ajlouni, Sheehan's Syndrome - A Review with Emphasis on the Hypothalamic - Pituitary Function, Journal of the Kuwait Medical Association, 22 (3): 219 - 224, 1988.

61. A. S. Sroujieh, M. Abu-Khalaf, A. Swaiss, G. R. Farah, H. El-Muhtaseb, K. M. Ajlouni, M. Zaheri and M. S. Tarawneh, Carcinoma of the Thyroid Glad (Report of 100 Cases), Jordan Medical Journal, 24 No. 2: 135-145, 1990.

62. M. A. Arnaout, Y. B Hamzeh, K.M. Ajlouni, Prolactin Responses to Vasoactive Intestinal Polypeptid and Throtropin Releasing Factor in Chronic Renal Failure Patients. 125: 651- 656, 1991.

63. M. A. Arnaout, K. M. Ajlouni, Prolactin Responses to Vasoactive Intestinal Polypeptide and Thyrotropin Releasing Factor In Patients with Hyperprolactinemia.

64. M. A. Arnaout and  K. Ajlouni, Plasma Vasopressin in Postpartum hypopituitarism: impaired response to osmotic stimuli, Acta Endocrinologica (copenh) 1992 Dec; 127 (6): 494-8.

65. M. A. Arnaout, A. S. Awidi, A. M. El-Najdawi, M. S. Khateeb and K. M. Ajlouni, arginine-Vasporessin and endothelium associated proteins in thyroid disease, Acta Endocrinologica (copenh). 1992 May; 126 (5): 399- 403.

66. M. A. Shaban, B.A. Ammari, K. M. Ajlouni and M. S. Tarawneh, Male Infertility: Hormonal Evaluation and Causes, Dirast (Pure and Applied Sciences), Vol. 21B, Number 6, 119-127, 1994.

67. Ajlouni K-History of informed medical consent. The lancet. 1995 Oct 7; 346 (8980-981.

68. Ajlouni K. Partnership: health services and medical education , Medical Education 1995; 29 Supplement 1: 61-62.

69. K. M. Ajlouni, M. A. Arnaout and Y. Qusous, Congenital Adrenal Hyperplasia Due to 11B-Hydroxylase Deficiency with Skeletal Abnormalities:  J. Endocrinol. Invest 1996 May; 19 (5):  316-319.

70. Jaddou H., Batieh A., Ajlouni K., Prevalence and associated factors of Hypertension: results from a three community- based survey, Jordan,  Journal    of  Human Hypertension, 1996 Dec; 10 (12) : 815-821.

71. Ajlouni K., Al-Khalidi U., Medical records, patient outcome, and peer review in eleventh century arab medicine. Annals of Saudi Medicine 1997, 17 : 326-327.

72. Batieha A., Jaddou H.,  Ajlouni K., Hyperlipidemia in Jordan: a community-based survey, Saudia Medical Journal, 1997; 18 : 279-284.

73. Ajlouni K., Jaddou H., Batieha A., Diabetes and impaired glucose tolerance in  Jordan: Prevalence and associated risk factors, Journal of Internal Medicine, 1998 Oct; 244(4):317-23.

74. Ajlouni K., Jaddou H., Batieha A., Obesity in Jordan, Internal Journal of Obesity and Related Metabolic Disorders, 1998 Jul; 22 (7): 624-628.

75. Ammari F., Batieha A., Jaddou H., Okashi M., Ajlouni K., A natural history of impaired glucose tolerance in North Jordan,  Practical Diabetes International, 1998; 15:139-142.

76. Younis E, Jarrah N, Abdeen G, Raqqad A, Tarawneh M, Ajlouni K.Anorexia Nervosa with Pancytopenia, Annals of Saudi Medicine,Vol 18.No 5,1998

77. EL-Shanti  H, Ajlouni K, Jarrah N, Druhan A, Lidral A:  Clinical and genetic heterogeneity of Wolfram syndrome. Am J Hum Genet 1998; 63 (suppl) A567. (American Society of Human Genetics Annual Meeting, Denver, Colorado, USA. Oct, 1998*.

78. Ajlouni K, Qusous Y, Khawaldeh AK, Jaddou H, Batiehah A, Ammari F, Zaheri M, Mashal A. Incidence of insulin-dependent diabetes mellitus in Jordanian children aged 0-14y during  1992-1996. Acta paediatr Suppl. 1999 Jan; 88.(427) 11-3.

79. Dahbour S, Jarrah N, Ajlouni K . Neurologic involvement in Wolfram Syndrome, Neurosciences 1999; Vo.4 (3):223-226.

80. Jarrah N, El-Shanti H, Shennak M, Ajlouni K. A case of Wolfram Syndrome in Triplets: Some Newly Recognized Features,Annals of Saudi Medicine, 1999; a. Vo 19:132-134.

81. Salem M, Ajlouni , K.  Diabetic Retinopathy Among Jordanians: Its Pattern, Severity, and some Associated Risk Factors,Diabetologia Croatica 28-1,1999.

82. Younis E, Ajlouni K. Insulin from Discovery to Analogues. Jordan Medical Journal, Vol.33, No.(2), Nov.1999.

83. EL-shanti H, Al-Salem M, El-Najjar M, Ajlouni K, Beck J, Sheffiled VC,. A nonsense mutation in the retinal specific guanylate cyclase gene is the cause of Leber congeital amaurosis in a large inbred  kindred from Jordan. J Med Genet. 1999 Nov;36 (11):862-5.

84. EL-Shanti  H, Ajlouni K, Jarrah N, Druhan A, Lidral A: The identification of a second Wolfram syndrome locus: Further evidence of locus heterogeneity. Proceedings of the Greenwood Genetics Center. XX david W. Smith Workshop on Malformations and Morphogenesis. Schlangenbad, Germany. August 1999*.

85. Maraga I,  Hijazi S.  Ajlouni K,  et al: Health in Jordan .-Abdul Hamid Shuman Foundation Arabic Foundation . Press 1999.

86. El-Shanti H, Lidral A, Jarrah N, Druhan L, Ajlouni K: Homozygosity Mapping Identifies an Additional Locus for Wolfram Syndrome on Chromosome  4q. Am J Hum Genet 2000; 66:1229-1236.

87. Nadim Jarrah, Kamel Ajlouni: Type 2 Diabetes Mellitus in Children .Jordan Medical Journal, 34,(1), May 2000

88. Jaddou Hy, Bateiha AM, Ajlouni KM: Prevalence, awareness and management of hypertension in a recently urbanised community, eastern Jordan, J.Human  Hypertension 2000..Aug; 14 (8):497-501.

89. Nadim Jarrah, Hatem El-Shanti, Ahmad Khier, Fatima Nouri Obeidat, Azmi Haddidi, Kamel Ajlouni: Familial disorder of sex determination in seven individuals from three related sibships, eur J Pediatr (2000) 159: 912-918 .

90. Al- sheyyab M, Jarrah N, Younis E, Shennak MM, Hadidi A, Awidi : Bleeding tendency in Wolfram syndrome: a newly identified feature with phenotype genotype correlation, Eur J Pediatr. 2001 Apr; 160 (4):243-6.

91. Khawaldeh AK,  Dabbas M, Abaddi M,  Batieha A, Jaddou H, Ajlouni K,: Prevalence of Diabetes and Abnormalities of Carbohydrate Metabolism in the Jordanian Aramed Forces Male Personnel, Journal of the Royal Medical Services Vol. 8  No.1 June 2001.

92. Jaddou H, Bateiha A, Khawaldeh AK, Goussous Y, Ajlouni K,: Blood Pressure Profile in School Children and Adolescents in Jordan, Annals of Saudi Medicine, Vol 21, No 1-2, 2001.

93. Hasan MA, Batieha A, Jadou H, Khawaldeh AK, Ajlouni K, : Growth status of  Jordanian  schoolchildren in military-funded schools., Eur J Clin Nutr. 2001 May ; 55(5):380-6.

94. Younis E, Jarrah N, Sroujieh AS, Al Hadidy A, Ajlouni K:  Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia, Endocr Pract. 2001 Sep-Oct; 7(5):375-8 .

95. Ajlouni K, Daradkeh T., Ajlouni H, Mubaidin A, Jarrah N,: De Novo Sleepwalking Associated with Hyperthyroidism, Sleep and Hypnosis 2001 May ;3(3):97-101.

96. Enas Younis, Heitham Ajlouni, Kamel Ajlouni: The Prevalence of Missed Hyperglycemia Among Jordan University Hospital Mortality Discharges. (1995-1997). Eastern Mediterranean Health J. 2001 Jan-Mar;7(1-2):46-51.

97. Hiyasat D, Dehyyat M,  Ajlouni S, Mubaidin A,  Till M, Hadidi A, El-shanti H, Ajlouni K,:Cerebellar hypoplasia, hypergonadotrophic hypogonadism, retinitis pigmentosa, alopecia, microcephaly, psychomotor retardation, and short stature: “D-CHRAMPS SYNDROME” ,Eur J Pediatr (2002); 161: 170-172 .

98. M. Al-Till, N. Jarrah, K. Ajlouni :Ophthalmologic Findings in Fifteen Patients with Wolfram Syndrome: European Journal of Ophthalmology, Eur J Ophthalmol 2002 ; Mar-Apr; 12(2):84-8.

99. Kamel Ajlouni, Nadim Jarrah, Mohammad El-Khateeb, Mohamed El-Zaheri, Hatem El –Shanti, and Andrew Lidral: Wolfram Syndrome: Identification of a phenotypic and Genotypic Variant from Jordan: American Journal of Medical Genetics (Semin. Med. Genet.) 115:61-65 (2002) .

100. Nadima Sh-Shegem, Abeer M. Alsheek Nasir, Abdel-Kareem Jbour, Anwar M. Batieha, Moh’d  S.El-Khateeb,, Kamel M. Ajlouni. :Effects of Short term Metformin Administration on Androgens in Normal Men,. Saudi Medical Journal. 2002; Vol.23 (8).

101. Rula Goussous, Ruba Barakat, Nadim Jarrah, M. Omar Abu Hijleh,  Mohamed M. El-Zaheri, Kamel Ajlouni: Hypocalcemia Resistant to 1,Alpha Hydroxyvitamin D Treated Successfully with 1,25 - Dihydroxyvitamin D. - Saudi Medical Journal .2002;Vol.24 (5).

102. A.K. Jbour,  A. Mubaidin, M. Dehyyat, K. Horani, M. Al-Till, H. El-Shanti, Azmi Hadidi, K. Ajlouni: Hypogonadotrophic hypogonadism, short stature, cerebellar ataxia , rod-cone retinal dystrophy, and hypersegmented neutrophils: a novel  disorder or a new variant of Boucher-Neuhauser syndrome,.  Journal Med Genetics  2003;40:2.

103. El-Shanti H, Ahmad M, Ajlouni K.: Alopecia universalis congenita, XY  gonadal dysgenesis and laryngomalacia: a novel malformation syndrome,.Eur J Pediatr 2003 Jan; 162 (1): 36-40.

104. AbdelRahman Radaideh,  Mohammad Al-Khateeb, Anwar M. Batieha, Abeer S. Naser, Kamel Ajlouni : Thyroid Function and Thyroid Autoimmunity in Patients with Type 1 Diabetes Mellitus,.Saudi Med J.2003 Apr; 24(4): 352-5.

105. Mjali Hassan, Anwar Batieha, Hashim Jaddou, Abdelkareem  Khawaldeh, Kamel Ajlouni:  Socio-economic Discrepancies in Growth Status of Jordanian Children in  Military-Run Schools at the Turn of the Twentieth Century ,. – Saudi Medical Journal 2003;Vol.24 (5).

106. H. Jaddou, A. Batieha, M.  S.El-Khateeb, Kamel M. Ajlouni : Epidemiology and management of hypertension  among bedouins in Northern Jordan, Saudi Medical Journal. 2003;Vol.24 (5).

107. Kamel Ajlouni: Values, qualifications , ethics and legal standards in Arabic (Islamic) Medicine,. Saudi Medical Journal 2003 ;vol.24(8):820-826.

108. Kamel Ajlouni: The Identity of Islamic Health Care System, Dolentium Hominum  No.52. Year xV111.  2003 no.1.

109. Nadim Jarrah, Kamel M. Ajlouni: Thyroid Hormone Effects on the Cardiovascula system in Health & Disease; Jordan Medical Journal, VOL.37. NO. (2) Nov 2003.

110. Mohammed S. El-Khateeb, Shadwan Mesri, Muhieddin Juma, Mohamed El-Zaheri, Kamel Ajlouni: Antibodies to Glutamic Acid Decarboxylase in Syrian and Jordanian Type 1 Diabetes Patients and Their Siblings, Annals of Saudi Medicine. 2003, Vol 23 (6):376-380.

111. Bassam M. Taher, Raed. A. Ghariabeh, Nadim. S. Jarrah, Azmy M. Hadidy Abdelrahman M. Radaideh, Kamel M. Ajlouni: Spontaneus ovarian hyperstimulation syndrome caused by hypothyroidism in an adult,. European Journal of Obstetrics and ynecology and Reproductive Biology.112 (2004) 107-109.

112. Dana Hiyasat,Muosa Abu Jbara,Azmi Taleb Ahmad, Nadim Jarrah & Kamel Ajlouni: Calcium & Phosphorus Metabolism; Their Regulating Hormones. Jordan Medical Journal, vol.38.No.(2) Nov 2004.

113. Kamel Ajlouni: Depression: An Islamic view: Causes and Treatment., Dolentium Hominum   N.55-(2004)107-110.

114. Fawaz L.Ammari, Heitham  K. Ajlouni,  Kamel M. Ajlouni: Age at menarche in  Jordanian girls,Saudi Med J 2004; Vol. 25 (2).

115. Hanan A.Hamamy, Heitham K. Ajlouni, and Kamel M.Ajlouni: Familial Monozygootic Twinning: Report  of an extended multi-generation family, Twin Research 2004. Vol Number (3):219-222.

116. Azmy Hadidiy, Nadim Jarrah, Maha Al-Till, Hatem El-  Shanti, Kamel  Ajlouni: Radiological finding in Wolfram syndrom, Saudi Med J. 2004 ; Vol. 25 (5).

117. Abdel Rahman M Radaideh, Mohamad K. Nusier, Fawaz. Amari, Anwar. Bateihaa, Mohammed El-Khateeb, Abeer Sheikh Naser , Kamel M. Ajlouni: Thyroid Dysfunction in Patients with Type 2 Diabetes Mellitus in Jordan;Saudi Medical J. 2004 ;vol. 25 (8):1046-1050.

118. Nael N.Sahhar, Azmi T. Ahmad ,Fawaz L. Ammari , Kamel Ajlouni:Dysregulation of growth hormne in acuired generalized lipodystrophy, Saudi Med J. 2004 ; vol.25(11):447-448

119. B.M.Taher, H.K. Ajlouni, H.A. Hamamy, N.S. Shegem, A.Y.Madanat and K.M. Ajlouni: Precocious Puberty at an endocrine centre in Jordan,Eur Jornal of Clinical Investigation (2004) 34,599-604.

120. Kamel M Ajlouni, Aly A. Misha’l: Obesity Adilemma of Modern Times. International Dimensions-and Jordan as a developing Country Model; Federation of Islamic Medical Associations, Year Book 2004.

121. Mousa A  Abujbara, Hanan Hamamy, Nadim S Jarrah, Nadima S Shegem and Kamel M Ajlouni:, Clinical And inheritance profiles of Kallmann Syndrome in Jordan. Reprod Health. 2004 Oct 24;1(1):5

122. Awwad Z, Abu-Hijleh M, Basri S, Shegem N, Murshidi M, Ajlouni.K: Penile measurements in normal adult Jordanians and in patients with erectile dysfunction. Int J Impot Res. 2005 Mar-Apr;17(2):191-5

123. Maha Al-Till, Kamel Ajlouni: Prevalence of Blindness and Visual Impairment among Jordanian Diabetics, Eur Jornal of Ophthalmology. 2005 Jan-Feb:15(1):62-8

124. Kamel M. Ajouni, Azmi T. Ahmad. Mohammad M. A-Zahiri, Fawwaz L. Ammari, Nadim S. Jarrah, Mousa A. Abujbara, Heitham K. Ajlouni, Tewfik K. Daradkeh: Sleepwalking  Associated With Hyperthyroidism; Endocrine Practice Vol -11- No.1 Jan/Feb 2005.

125. Hamamy HA, Daas HA, Shegem NS. Al-Hadidy AM, Ajlouni D.:Cockayne syndrome in 2 siblings, Saudi Med J. 2005 May ; 26(5):875-9.

126. Hamamy H, Jamhawi L, Al-Darawsheh J, Ajlouni K.: Consanguineous marriages in Jordan: why is the rate changing with time? Clin  Genet. 2005 Jun;67(6):511-6.

127. Taher BM,Hamamy HA, Nino MI, Ajlouni KM.: Precocious puberty  revealing severe hypothyroidism;Saudi Med J. 2005 Jul;26(7).

128. Muwafag Hyari, Hanan Hamamy, Muries Barham, Azmy Al-Hadidy, Kamel Ajlouni  : Familial short fifth metacarpals and insulin resistance. Skeletal Radiology 2005.

129. H. Hamamy, A. Masri, K. Ajlouni:  Wrinkly skin syndrome. Clinical and   Experimental Dermatology, 30, 578–602 2005.

130. Taher Bassam, Kamel Ajlouni,: A case of ovarian enlargement  in severe primary  hypothyroidism and review of the literature; Ann Saudi Med 26 (1) January-February 2006.

131. Khatib FA, Jarrah NS, Shegem NS, Bateiha AM, Abu-Ali RM, Ajlouni KM:, Sexual dysfunction among Jordanian men with diabetes ;Saudi Med J. 2006 Mar;27(3)

132. H.A. Hamamy, A.masri, A. Al-hadidy, M. El-Zaheri, K. Ajlouni,: Etiological and consanguinity profiles of disorders referred to a genetic counselling clinic in Jordan. European Journal of Human Genetics Vol 14 Supplement 1 May 2006*.

133. Nahla M. Khawaja, Bassam M. Taher,, Muries E. Barham, , Azmi T. Ahmad,   Hanan A. Hamamy, Kamel M. Ajlouni: PITUITARY ENLARGEMENT IN PATIENTS   WITH PRIMARY HYPOTHYROIDISM. Endocrine practice Vol 12  No. 1 January/ February 2006.

134. H. Hamamy, N Saleh, M. Oldridge, Al-Hadidy, K. Ajlouni: Brachydactyly type B1: report o a family with de Novo ROR2 mutation, Clinical Genetics, 2006:70:538-540*.

135. Hanan Hamamy, Muries Barham, Abd-ElKarim Alkhawaldeh, David Cockburn, Helen Snowden, K. Ajlouni: Alstrom syndrome in four sibs from Northern Jordan. Ann Saudi Med 26(6) Nov.December 2006

136. Hanan Hamamy, Sana Al-Hait, Aladin Alwan, Kamel Ajlouni: Jordan. Communities and Community Genetics. Community Genetics2007;10:52-60

137. Kamel Ajlouni ,Yousef Khader, Anwar Bateiha,: An increase in prevalence of diabetes mellitus in Jordan during ten years: Journal of Diabetes and Its Complications. In press.

138. Azmi T. Ahmad, Mousa Abu Jbara, Dana Hiyasat, Kamel M.   Ajlouni: The standard clinical smell testing protocol of the National Center for Diabetes, Endocrinology and Metabolism in Amman, Jordan: JOR test. Am.J. of  otolaryngology. 28 (2007) 388-391.

139. Hanan A. Hamamy , Ahmad S. Teebi , Kamaldine Oudjhane , N.N. Shegem , K.M. Ajlouni: Severe hypertelorism, midface prominence, prominent/simple ears, severe myopia, borderline intelligence, and bone fragility in two brothers: New syndrome.  American Journal of Medical Genetics. Pages 229 – 234 17 Jan 2007.

140. A. Batieha,  H. Alkadhi, Y. Hamzeh, M. Ayoub, N. Al-Akash, and K.A. Ajlouni: Epidemiology and cost of haemodialysis in Jordan. EMHJ Vol.13,N3,2007.

141. Yousef  Khader, Anwar Batieha. Mohammad Al- Khateeb, Abeer AlShaikh, Kamel Ajlouni: High prevalence of the Metabolic Syndrome among Northern Jordanians. Journal of Diabetes and Its Complications. 21(2007) 214-219.

142. S.Abdalla, A.T.Ahmad, A. Batieha and Kamel Ajlouni: Diabetes Mellitus: the leading cause of  haemodialysis in Jordan.  EMHJ Vol.13,  No. 4, 2007.

143. Hanan Hamamy, Amira Masri, Azmy Al-Hadidy & Kamel Ajlouni: Consanguinity and genetic disorders: profile from Jordan. SMJ 2007 Jul;28(7):1015-7.

144. Amr S, Heisey C, Zhang M, Xia XJ, Shows KH, Ajlouni K, Pandya A, Satin LS, El-Shanti H, Shiang R: A Homozygous Mutation in a Novel Zinc-Finger Protein, ERIS, Is Responsible for Wolfram Syndrome. Am.J.H.Gen. Vol.81 Oct. 2007 .

145. Khader Y, Batieha A, Ajlouni H, El-Kateeb, Ajlouni K. Obesity in Jordan: Prevalence, associated factors, co-morbidities, and change in prevalence over ten years. Metabolic Syndrome and Related Disorders.  2008; 6(2): 113-20.

146. Ruba M. Abu Ali, , Rabaa M. Al Hajeri , Yousef S. Khader , Nadima S. Shegem Kamel M. Ajlouni. Sexual Dysfunction in Jordanian Diabetic Women. Diabetes Care. In press.

147. Mousa A. Abujbara, Kamel M. Ajlouni, Do we need to treat impaired glucose tolerance and impaired fasting glucose? International Journal of Diabetes Mellitus. In press.

148. Hisham Jarbhou, Hanan Hamamy, Azmy Al-Hadidy and Kamel Ajlouni. Cenani– Lenz syndactyly with facial dysmorphism, hypothyroidism, and renal hypoplasia: a case report. Clinical Dysmorphology.